The University of Maryland provides a one-year (July 1 to June 30), post-doctoral, ASHP-accredited residency training program in psychiatric pharmacy (PGY2).

The University of Maryland Baltimore, School of Pharmacy offers a one-year, ASHP-accredited, PGY-2 residency in psychiatric pharmacy practice. This residency combines clinical, teaching, and administrative components to provide the resident with the necessary skills to pursue leadership roles in the field and to use critical thinking in applied problem-solving. Upon successful completion of this program, the resident will have expert skills and competencies in psychiatric pharmacy practice.  The PGY2 pharmacy residency in psychiatry is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with psychiatric and neuropsychiatric disorders. By providing the resident with opportunities to engage in practice, research, and education, the purpose of this residency program is to build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. This PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete this accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

As part of its accreditation by the American Society of Health-System Pharmacists (ASHP), this program is committed to the following general purpose:

Postgraduate Year 2 (PGY2) pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and Postgraduate Year 1 (PGY1) pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).

Because this residency program is accreditated by the American Society of Health-System Pharmacists, the resident will complete the following ASHP-established outcomes:

  • Serve as an authoritative resource on the optimal use of medications used to treat individuals with psychiatric and neuropsychiatric disorders.
  • Optimize the outcomes of diverse populations of inpatients and outpatients with a variety of psychiatric and neuropsychiatric disorders and a range of complexity of problems by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.
  • Demonstrate leadership and practice management skills.
  • Demonstrate excellence in the provision of training or educational activities for health care professionals, health care professionals in training, and the public.
  • Evaluate and improve the medication-use process in psychiatric and neuropsychiatric patient care areas.
  • Conduct psychiatric pharmacy practice research.

Additionally, our program adheres to the Goals and Objectives for a Post-Graduate Year Two Program in Psychiatric Pharmacy set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.

About the Mental Health Program:

The Mental Health Program was established in 1983 as a cooperative effort of the Mental Hygiene Administration (MHA), the Department of Health and Mental Hygiene, the state of Maryland, and the School of Pharmacy. The primary objectives include the improvement of pharmacy services in the state mental health facilities and the education of pharmacy students in mental health. The program operates the State of Maryland Clozapine Authorization and Monitoring Program and coordinates the Statewide Pharmacy and Therapeutics Committee. The Mental Health Program has been instrumental in aiding facilities in adhering to state and federal regulations and standards, and in the development of the School of Pharmacy's curriculum in mental health. The Psychiatric Pharmacy Residency Program was established in 1989 and was the first University of Maryland, School of Pharmacy residency.

Learning Experiences:

Patient Care Rotations:

  • Adult Psychiatric Continuing Care I (required)
  • Adult Psychiatric Continuing Care II (required)
  • Geriatric Psychiatry (required)
  • Adolescent Psychiatry (required)
  • Acute Psychiatry I (required)
  • Acute Psychiatry II (required)
  • Developmental Disabilities/Neurology (required)
  • Elective I
  • Elective II

Ambulatory Care Rotation:

  • Psychiatric Ambulatory Clinic Longitudinal (required)

Longitudinal Rotations:

  • Performance Improvement (required)
  • Teaching (required)
  • Research (required)

Rotation Sites:

Duties include, but are not limited to, interdisciplinary team participation, drug information, medication regimen review, medication consultations, and patient education. Required inpatient rotations occur at two MHA-funded psychiatric facilities in the state of Maryland:

The sites listed below are utilized primarily for elective rotations:

Additional Required Activities:

  • Complete one Pharmacotherapy Grand Rounds presentation (ACPE Accredited); attend peer presentations.
  • Complete one formulary review for DHMH Pharmacy and Therapeutics Committee.
  • Complete one medication utilization evaluation (MUE).
  • Design and complete a community service education event with resident peers.
  • Attend Professional Development Series (8).
  • Complete a clinical research project, which will be presented to the Department of Pharmacy Practice and Science. The project will be written up as a manuscript for publication. It is recommended that the project be presented at a national organizational meeting such as College of Psychiatric and Neurologic Pharmacists (CPNP) annual meeting.


Residents in this program are required to teach 40 hours per semester and will be assigned to a variety of teaching experiences at the University of Maryland School of Pharmacy, including didactic lectures, discussion groups, laboratory exercises, and other assignments as determined by the Department of Pharmacy Practice and Science.

Residents must also precept students on clinical psychiatric rotations through the University of Maryland School Of Pharmacy and serve as the primary preceptor for at least one student. The resident may also participate in an optional teaching certificate program.

Number of Available Positions: 1

Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (class rank must be submitted if pass/fail). The Doctor of Pharmacy (PharmD) degree and Maryland Pharmacy licensure are required. Residents must complete a PGY1 residency prior to starting.


  • The resident will be paid a stipend, two weeks paid vacation, 11 holidays, and 3 personal days.
  • The resident will be covered under a comprehensive medical plan through the University of Maryland, Baltimore (includes pharmacy and dental plans).
  • The resident will receive a travel stipend.

Application Process:

Applicants must possess a Doctor of Pharmacy degree and have completed an ASHP-accredited residency in pharmacy practice. The resident will be required to become a licensed pharmacist in the state of Maryland.

Applications for this program will only be accepted through PhORCAS. Reference writers should use the standard reference template in PhORCAS.

Application requirements:

  • Letter of intent
  • Curriculum vitae
  • Letters of recommendation (3)
  • Official transcripts

The application deadline is January 1.

International students and permanent residents should contact before applying.

Residents who match to this program will be required to come to Baltimore in advance of the July 1st start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.

Contact Information:

Bethany A DiPaula, PharmD, BCPP
Director, Psychiatric Pharmacy Residency
Professor, University of Maryland School of Pharmacy
Director of Pharmacy, Springfield Hospital Center
Phone: (410) 970-7136